These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 22182771)

  • 1. Multifunctional PEGylated 2C5-immunoliposomes containing pH-sensitive bonds and TAT peptide for enhanced tumor cell internalization and cytotoxicity.
    Koren E; Apte A; Jani A; Torchilin VP
    J Control Release; 2012 Jun; 160(2):264-73. PubMed ID: 22182771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxorubicin in TAT peptide-modified multifunctional immunoliposomes demonstrates increased activity against both drug-sensitive and drug-resistant ovarian cancer models.
    Apte A; Koren E; Koshkaryev A; Torchilin VP
    Cancer Biol Ther; 2014 Jan; 15(1):69-80. PubMed ID: 24145298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers.
    Sawant RM; Hurley JP; Salmaso S; Kale A; Tolcheva E; Levchenko TS; Torchilin VP
    Bioconjug Chem; 2006; 17(4):943-9. PubMed ID: 16848401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Smart" drug carriers: PEGylated TATp-modified pH-sensitive liposomes.
    Kale AA; Torchilin VP
    J Liposome Res; 2007; 17(3-4):197-203. PubMed ID: 18027240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-penetrating TAT peptide in drug delivery systems: proteolytic stability requirements.
    Koren E; Apte A; Sawant RR; Grunwald J; Torchilin VP
    Drug Deliv; 2011 Jul; 18(5):377-84. PubMed ID: 21438724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Environment-responsive multifunctional liposomes.
    Kale AA; Torchilin VP
    Methods Mol Biol; 2010; 605():213-42. PubMed ID: 20072884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An efficient PEGylated liposomal nanocarrier containing cell-penetrating peptide and pH-sensitive hydrazone bond for enhancing tumor-targeted drug delivery.
    Ding Y; Sun D; Wang GL; Yang HG; Xu HF; Chen JH; Xie Y; Wang ZQ
    Int J Nanomedicine; 2015; 10():6199-214. PubMed ID: 26491292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced cytotoxicity of monoclonal anticancer antibody 2C5-modified doxorubicin-loaded PEGylated liposomes against various tumor cell lines.
    Elbayoumi TA; Torchilin VP
    Eur J Pharm Sci; 2007 Nov; 32(3):159-68. PubMed ID: 17707615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of the novel PEG-PE-based polymer for the reversible attachment of specific ligands to liposomes: synthesis and in vitro characterization.
    Biswas S; Dodwadkar NS; Sawant RR; Torchilin VP
    Bioconjug Chem; 2011 Oct; 22(10):2005-13. PubMed ID: 21870873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced transfection of tumor cells in vivo using "Smart" pH-sensitive TAT-modified pegylated liposomes.
    Kale AA; Torchilin VP
    J Drug Target; 2007; 15(7-8):538-45. PubMed ID: 17671900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pH-Sensitive PEGylated Liposomal Silybin: Synthesis, In Vitro and In Vivo Anti-Tumor Evaluation.
    Gheybi F; Alavizadeh SH; Rezayat SM; Hatamipour M; Akhtari J; Faridi Majidi R; Badiee A; Jaafari MR
    J Pharm Sci; 2021 Dec; 110(12):3919-3928. PubMed ID: 34418455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accumulation and toxicity of antibody-targeted doxorubicin-loaded PEG-PE micelles in ovarian cancer cell spheroid model.
    Perche F; Patel NR; Torchilin VP
    J Control Release; 2012 Nov; 164(1):95-102. PubMed ID: 22974689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(ethylene glycol) shell-sheddable TAT-modified core cross-linked nano-micelles: TAT-enhanced cellular uptake and lysosomal pH-triggered doxorubicin release.
    Zhang Y; Xiao Y; Huang Y; He Y; Xu Y; Lu W; Yu J
    Colloids Surf B Biointerfaces; 2020 Apr; 188():110772. PubMed ID: 31999965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloprotease 2-responsive multifunctional liposomal nanocarrier for enhanced tumor targeting.
    Zhu L; Kate P; Torchilin VP
    ACS Nano; 2012 Apr; 6(4):3491-8. PubMed ID: 22409425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-targeted liposomes: doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibody.
    Lukyanov AN; Elbayoumi TA; Chakilam AR; Torchilin VP
    J Control Release; 2004 Nov; 100(1):135-44. PubMed ID: 15491817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Copper-Mediated Disulfiram-Loaded pH-Triggered PEG-Shedding TAT Peptide-Modified Lipid Nanocapsules for Use in Tumor Therapy.
    Zhang L; Tian B; Li Y; Lei T; Meng J; Yang L; Zhang Y; Chen F; Zhang H; Xu H; Zhang Y; Tang X
    ACS Appl Mater Interfaces; 2015 Nov; 7(45):25147-61. PubMed ID: 26501354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted Delivery of Combination Therapeutics Using Monoclonal Antibody 2C5-Modified Immunoliposomes for Cancer Therapy.
    Narayanaswamy R; Torchilin VP
    Pharm Res; 2021 Mar; 38(3):429-450. PubMed ID: 33655395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity.
    Jung SH; Jung SH; Seong H; Cho SH; Jeong KS; Shin BC
    Int J Pharm; 2009 Dec; 382(1-2):254-61. PubMed ID: 19666094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo study of doxorubicin-loaded cell-penetrating peptide-modified pH-sensitive liposomes: biocompatibility, bio-distribution, and pharmacodynamics in BALB/c nude mice bearing human breast tumors.
    Ding Y; Cui W; Sun D; Wang GL; Hei Y; Meng S; Chen JH; Xie Y; Wang ZQ
    Drug Des Devel Ther; 2017; 11():3105-3117. PubMed ID: 29123382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation, characterization, and antitumor activity of paclitaxel-loaded folic acid modified and TAT peptide conjugated PEGylated polymeric liposomes.
    Niu R; Zhao P; Wang H; Yu M; Cao S; Zhang F; Chang J
    J Drug Target; 2011 Jun; 19(5):373-81. PubMed ID: 20677917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.